PATENT CLAIM ANALYSIS

Application Number: 16415561
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "178000"]

Abstract:
The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.

Claim (Index 183):
The method of  claim 169 , wherein said one or more pharmaceutically-acceptable excipients comprises talc, microcrystalline cellulose, anhydrous lactose, silicon dioxide, and magnesium stearate.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 100.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16415599', '14748147', '15433427', '16223522', '16223556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8240205987397318
- 35 USC 102 Novelty (BERT): 0.6207350943093667
- Combined Prediction Score: 0.8036920482966953
- Mean Citation Score: 552.042656
- Max Citation Score: 792.7397
- Similarity Product: 492.90764165233367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test